Strs Ohio reduced its position in Johnson & Johnson (NYSE:JNJ) by 0.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,745,978 shares of the company’s stock after selling 7,251 shares during the period. Johnson & Johnson accounts for about 1.0% of Strs Ohio’s portfolio, making the stock its 11th largest position. Strs Ohio owned approximately 0.07% of Johnson & Johnson worth $226,994,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Harding Loevner LP purchased a new position in shares of Johnson & Johnson in the 2nd quarter valued at approximately $106,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its position in shares of Johnson & Johnson by 29.9% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock valued at $115,000 after purchasing an additional 200 shares during the last quarter. Lenox Wealth Advisors Inc. raised its position in shares of Johnson & Johnson by 0.6% in the 2nd quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock valued at $116,000 after purchasing an additional 5 shares during the last quarter. Mountain Capital Investment Advisors Inc purchased a new position in shares of Johnson & Johnson in the 2nd quarter valued at approximately $124,000. Finally, Shine Investment Advisory Services Inc. purchased a new position in shares of Johnson & Johnson in the 2nd quarter valued at approximately $177,000. Institutional investors and hedge funds own 65.70% of the company’s stock.
Several equities analysts recently commented on the stock. Piper Jaffray Companies reaffirmed a “hold” rating and issued a $120.00 price objective on shares of Johnson & Johnson in a research report on Wednesday, October 4th. Vetr lowered shares of Johnson & Johnson from a “hold” rating to a “sell” rating and set a $130.49 price target for the company. in a research report on Monday, September 18th. Stifel Nicolaus raised their price target on shares of Johnson & Johnson from $140.00 to $142.00 and gave the stock a “hold” rating in a research report on Wednesday, October 18th. Wells Fargo & Co raised shares of Johnson & Johnson from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $140.00 to $149.00 in a research report on Monday, October 9th. Finally, JPMorgan Chase & Co. lowered shares of Johnson & Johnson from an “overweight” rating to a “neutral” rating in a research report on Tuesday, January 2nd. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and eleven have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $145.94.
Shares of Johnson & Johnson (JNJ) opened at $145.76 on Friday. The company has a market cap of $391,590.00, a P/E ratio of 25.31, a PEG ratio of 2.67 and a beta of 0.80. Johnson & Johnson has a one year low of $110.76 and a one year high of $146.42. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.02 and a current ratio of 1.32.
Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings results on Tuesday, October 17th. The company reported $1.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. The firm had revenue of $19.65 billion for the quarter, compared to analysts’ expectations of $19.29 billion. During the same quarter last year, the company earned $1.68 EPS. The firm’s revenue for the quarter was up 10.3% compared to the same quarter last year. research analysts forecast that Johnson & Johnson will post 7.28 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Tuesday, February 27th will be paid a $0.84 dividend. The ex-dividend date of this dividend is Monday, February 26th. This represents a $3.36 dividend on an annualized basis and a yield of 2.31%. Johnson & Johnson’s dividend payout ratio is currently 58.33%.
ILLEGAL ACTIVITY NOTICE: This piece was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://ledgergazette.com/2018/01/13/johnson-johnson-jnj-shares-sold-by-strs-ohio.html.
Johnson & Johnson Profile
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.